Item request has been placed!

Item request cannot be made.

Processing Request

Additional file 8 of Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody

Item request has been placed!

Item request cannot be made.

Processing Request

اقرأ أكثر حفظ في قائمتي

المؤلفون: Yutaro Kaneko (10433586); Ryo Hatano (513315); Naoto Hirota (10433589); Nicolas Isambert (2186692); Véronique Trillet-Lenoir (3457715); Benoit You (3457706); Jérôme Alexandre (6504179); Gérard Zalcman (310344); Fanny Valleix (10433592); Thomas Podoll (10433595); Yoshimi Umezawa (10433598); Seiichi Takao (10433601); Satoshi Iwata (425199); Osamu Hosono (290916); Tetsuo Taguchi (10433604); Taketo Yamada (135877); Nam H. Dang (513317); Kei Ohnuma (408118); Eric Angevin (10433607); Chikao Morimoto (290914)
الموضوع:
Medicine; Cell Biology; Pharmacology; Biotechnology; Cancer; Serum soluble CD26/dipeptidyl peptidase 4; YS110; Prognostic biomarker; Cancer therapy
نوع التسجيلة:
conference object
اللغة:
unknown

معلومة اضافية
- الموضوع:
  2021
- Collection:
  Smithsonian Institution: Digital Repository
- نبذة مختصرة :
  Additional file 8: Table S7. Correlation between serum sCD26/DPP4 titer variation (%) and tumor volume change (%) or PFS (days) in 9 MM, male cases with Q2W administration by PPMC or SRDC analysis.
- Relation:
  https://figshare.com/articles/presentation/Additional_file_8_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302959
- الرقم المعرف:
  10.6084/m9.figshare.14302959.v1
- Rights:
  CC BY + CC0
- الرقم المعرف:
  edsbas.7FB86B1E

تعليقات

No Comments.